Micron advances with AI growth, strong results, a geopolitical moat, DCF upside near 375, and risks requiring prudent entry.

Despite growth decelerating in Q3, Innodata saw a significant acceleration in DDS revenues outside its lead customer. Read ...

Q3 2025 Earnings Call Transcript November 14, 2025 MiNK Therapeutics, Inc. beats earnings expectations. Reported EPS is ...